Jean M Connors
Jean M Connors
Physician, brigham and women's hospital
Verified email at
Cited by
Cited by
Post-acute COVID-19 syndrome
A Nalbandian, K Sehgal, A Gupta, MV Madhavan, C McGroder, ...
Nature medicine 27 (4), 601-615, 2021
COVID-19 and its implications for thrombosis and anticoagulation
JM Connors, JH Levy
Blood, The Journal of the American Society of Hematology 135 (23), 2033-2040, 2020
Thrombotic thrombocytopenic purpura associated with clopidogrel
CL Bennett, JM Connors, JM Carwile, JL Moake, WR Bell, SR Tarantolo, ...
New England Journal of Medicine 342 (24), 1773-1777, 2000
Apixaban for the treatment of venous thromboembolism associated with cancer
G Agnelli, C Becattini, G Meyer, A Muņoz, MV Huisman, JM Connors, ...
New England Journal of Medicine 382 (17), 1599-1607, 2020
Thromboinflammation and the hypercoagulability of COVID‐19
JM Connors, JH Levy
Journal of thrombosis and haemostasis 18 (7), 1559-1561, 2020
Scientific and standardization committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with …
AC Spyropoulos, JH Levy, W Ageno, JM Connors, BJ Hunt, T Iba, M Levi, ...
Journal of Thrombosis and Haemostasis 18 (8), 1859-1865, 2020
Coagulopathy of coronavirus disease 2019
T Iba, JH Levy, M Levi, JM Connors, J Thachil
Critical care medicine, 2020
The unique characteristics of COVID-19 coagulopathy
T Iba, JH Levy, JM Connors, TE Warkentin, J Thachil, M Levi
Critical care 24 (1), 1-8, 2020
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
D Farge, C Frere, JM Connors, C Ay, AA Khorana, A Munoz, B Brenner, ...
The Lancet Oncology 20 (10), e566-e581, 2019
The coagulopathy, endotheliopathy, and vasculitis of COVID-19
T Iba, JM Connors, JH Levy
Inflammation Research 69, 1181-1189, 2020
Thrombophilia testing and venous thrombosis
JM Connors
New England Journal of Medicine 377 (12), 1177-1187, 2017
Guidance for the treatment of deep vein thrombosis and pulmonary embolism
MB Streiff, G Agnelli, JM Connors, M Crowther, S Eichinger, R Lopes, ...
Journal of thrombosis and thrombolysis 41, 32-67, 2016
Tumor promoters block tyrosine-specific phosphorylation of the epidermal growth factor receptor.
BA Friedman, AR Frackelton Jr, AH Ross, JM Connors, H Fujiki, ...
Proceedings of the National Academy of Sciences 81 (10), 3034-3038, 1984
Cord blood leptin and insulin-like growth factor levels are independent predictors of fetal growth
H Christou, JM Connors, M Ziotopoulou, V Hatzidakis, ...
The Journal of Clinical Endocrinology & Metabolism 86 (2), 935-938, 2001
The frequency and management of asparaginase‐related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana‐Farber Cancer Institute …
RF Grace, SE Dahlberg, D Neuberg, SE Sallan, JM Connors, EJ Neufeld, ...
British journal of haematology 152 (4), 452-459, 2011
New oral anticoagulants and the cancer patient
NJ Short, JM Connors
The oncologist 19 (1), 82-93, 2014
Effect of antithrombotic therapy on clinical outcomes in outpatients with clinically stable symptomatic COVID-19: the ACTIV-4B randomized clinical trial
JM Connors, MM Brooks, FC Sciurba, JA Krishnan, JR Bledsoe, ...
Jama 326 (17), 1703-1712, 2021
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review
AH Talasaz, P Sadeghipour, H Kakavand, M Aghakouchakzadeh, ...
Journal of the American College of Cardiology 77 (15), 1903-1921, 2021
d-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy: A Cohort Study
C Kearon, FA Spencer, D O'Keeffe, S Parpia, S Schulman, T Baglin, ...
Annals of internal medicine 162 (1), 27-34, 2015
Evaluation of dose-reduced direct oral anticoagulant therapy
ME Barra, J Fanikos, JM Connors, KW Sylvester, G Piazza, SZ Goldhaber
The American Journal of Medicine 129 (11), 1198-1204, 2016
The system can't perform the operation now. Try again later.
Articles 1–20